vs
Side-by-side financial comparison of e.l.f. Beauty, Inc. (ELF) and Beauty Health Co (SKIN), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
e.l.f. Beauty, Inc. is the larger business by last-quarter revenue ($489.5M vs $82.4M, roughly 5.9× Beauty Health Co). e.l.f. Beauty, Inc. runs the higher net margin — 8.0% vs -9.8%, a 17.9% gap on every dollar of revenue. On growth, e.l.f. Beauty, Inc. posted the faster year-over-year revenue change (37.8% vs -1.3%). e.l.f. Beauty, Inc. produced more free cash flow last quarter ($52.8M vs $15.1M).
e.l.f. Beauty, Inc. is an American cosmetics brand based in Oakland, California. It was founded by Joseph Shamah and Scott Vincent Borba in 2004. The company sells items include bath and skin-care products, mineral-based makeup, professional tools, eyeliners, lipstick, glosses, blushes, bronzers, brushes and mascara. Its products are sold in 18 countries and in several stores including Target, Kmart, Dollar General and Walmart. Over half the company's sales come from its website, which is als...
Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.
ELF vs SKIN — Head-to-Head
Income Statement — Q3 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $489.5M | $82.4M |
| Net Profit | $39.4M | $-8.1M |
| Gross Margin | 71.0% | 64.4% |
| Operating Margin | 13.8% | 0.2% |
| Net Margin | 8.0% | -9.8% |
| Revenue YoY | 37.8% | -1.3% |
| Net Profit YoY | 128.1% | 21.5% |
| EPS (diluted) | $0.65 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $489.5M | $82.4M | ||
| Q3 25 | $343.9M | $70.7M | ||
| Q2 25 | $353.7M | $78.2M | ||
| Q1 25 | — | $69.6M | ||
| Q4 24 | — | $83.5M | ||
| Q3 24 | — | $78.8M | ||
| Q2 24 | — | $90.6M | ||
| Q1 24 | — | $81.4M |
| Q4 25 | $39.4M | $-8.1M | ||
| Q3 25 | $3.0M | $-11.0M | ||
| Q2 25 | $33.3M | $19.7M | ||
| Q1 25 | — | $-10.1M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | — | $-18.3M | ||
| Q2 24 | — | $202.0K | ||
| Q1 24 | — | $-679.0K |
| Q4 25 | 71.0% | 64.4% | ||
| Q3 25 | 69.4% | 64.6% | ||
| Q2 25 | 69.1% | 62.8% | ||
| Q1 25 | — | 69.8% | ||
| Q4 24 | — | 62.7% | ||
| Q3 24 | — | 51.6% | ||
| Q2 24 | — | 45.2% | ||
| Q1 24 | — | 59.4% |
| Q4 25 | 13.8% | 0.2% | ||
| Q3 25 | 2.2% | -8.8% | ||
| Q2 25 | 13.8% | -3.5% | ||
| Q1 25 | — | -17.3% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | — | -27.3% | ||
| Q2 24 | — | -24.4% | ||
| Q1 24 | — | -20.9% |
| Q4 25 | 8.0% | -9.8% | ||
| Q3 25 | 0.9% | -15.6% | ||
| Q2 25 | 9.4% | 25.2% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | -12.4% | ||
| Q3 24 | — | -23.2% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | -0.8% |
| Q4 25 | $0.65 | $-0.02 | ||
| Q3 25 | $0.05 | $-0.09 | ||
| Q2 25 | $0.58 | $0.03 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.10 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $196.8M | — |
| Total DebtLower is stronger | $816.7M | — |
| Stockholders' EquityBook value | $1.2B | $61.1M |
| Total Assets | $2.3B | $499.8M |
| Debt / EquityLower = less leverage | 0.70× | — |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $196.8M | — | ||
| Q3 25 | $194.4M | — | ||
| Q2 25 | $170.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $816.7M | — | ||
| Q3 25 | $831.6M | $363.4M | ||
| Q2 25 | $256.7M | $363.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $552.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $61.1M | ||
| Q3 25 | $1.1B | $65.7M | ||
| Q2 25 | $804.9M | $74.0M | ||
| Q1 25 | — | $46.1M | ||
| Q4 24 | — | $51.8M | ||
| Q3 24 | — | $59.7M | ||
| Q2 24 | — | $69.2M | ||
| Q1 24 | — | $63.3M |
| Q4 25 | $2.3B | $499.8M | ||
| Q3 25 | $2.3B | $503.6M | ||
| Q2 25 | $1.3B | $507.6M | ||
| Q1 25 | — | $673.8M | ||
| Q4 24 | — | $685.7M | ||
| Q3 24 | — | $699.5M | ||
| Q2 24 | — | $711.8M | ||
| Q1 24 | — | $844.7M |
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.73× | 5.53× | ||
| Q2 25 | 0.32× | 4.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $59.4M | $15.2M |
| Free Cash FlowOCF − Capex | $52.8M | $15.1M |
| FCF MarginFCF / Revenue | 10.8% | 18.3% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | 1.4% | 0.2% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | 1.51× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $37.2M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $59.4M | $15.2M | ||
| Q3 25 | $23.4M | $9.6M | ||
| Q2 25 | $27.2M | $9.6M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $-16.9M |
| Q4 25 | $52.8M | $15.1M | ||
| Q3 25 | $16.6M | $9.6M | ||
| Q2 25 | $20.1M | $9.6M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $5.9M | ||
| Q1 24 | — | $-17.2M |
| Q4 25 | 10.8% | 18.3% | ||
| Q3 25 | 4.8% | 13.6% | ||
| Q2 25 | 5.7% | 12.2% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | -21.1% |
| Q4 25 | 1.4% | 0.2% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 2.0% | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | 1.51× | — | ||
| Q3 25 | 7.82× | — | ||
| Q2 25 | 0.82× | 0.49× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 30.70× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
ELF
Segment breakdown not available.
SKIN
| Consumables | $57.7M | 70% |
| Delivery Systems | $24.7M | 30% |